WGS Q2 volumes rise 32% on new markets and automation
WGS said Q2 volumes grew 32%, attributing momentum to core channels and expansion into primary care and prenatal markets underway. Management cited untapped potential in geneticists, pediatric neurology and NICU, plus collection-rate and gross-margin improvements.
Strong Q2 growth was driven by core channels, with significant untapped potential still in geneticists, pediatric neurology and NICU. Expansion into primary care and prenatal markets is under way, supported by new guidelines and operational improvements. Collection rates and gross margins are e...